In March 2025, the company declared new designs for a direct-to-buyer featuring of its Wegovy weight loss drug. The company established a brand new pharmacy, referred to as NovoCare, which would charge consumers $499 every month for usage of the drug, a lot less than half the cost of the drug by means of other pharmaceutical distribution networks.[